Revolutionizing Cardiac Ablation Technology
Field Medical Inc. is making waves in the cardiac treatment arena with a significant announcement about its cutting-edge FieldForce™ Ablation System. The company will be presenting groundbreaking research at the upcoming Heart Rhythm Society meeting, underscoring its leadership in the field of cardiac pulsed field ablation technology. With eight scientific presentations planned, including live demonstrations and key symposiums, the company is set to captivate an audience of over 9,000 participants from across the globe.
Heart Rhythm Society 2025 Highlights
The Heart Rhythm Society 2025, a prestigious global event dedicated to heart rhythm science, provides Field Medical with a platform to showcase its innovative technology. The meeting will take place in a dynamic environment featuring the latest research findings and technological enhancements in cardiac care. Field Medical is positioned prominently within this vibrant setting, promising insightful presentations and discussions on the future of ventricular tachycardia (VT) treatment.
FieldForce Ablation System Features
The FieldForce Ablation System is designed specifically for handling complex cases of scar-related VT. This innovative device is engineered to enable precise focal pulsed field ablation, allowing for the creation of full-thickness transmural lesions, which is crucial in treating difficult arrhythmias effectively. According to the CEO and founder, Dr. Steven Mickelsen, this technology not only signifies a step forward but may also set a new standard in electrophysiology.
Clinical Trials and Data Presentation
At the conference, one of the key highlights will be the late-breaking presentation of the VCAS trial results. This trial represents the first-in-human evaluation of the focal PFA approach specifically targeted at treating scar-related VT. The public can expect a compelling presentation on April 27, delivering insights into the acute outcomes experienced during the trial.
Live Demonstrations and Panel Discussions
Throughout the event, Field Medical's FieldForce technology will be at the forefront of live case demonstrations. Experts in the field, including noted electrophysiologists, will demonstrate live interactions with the ablation system, facilitating a real-time understanding of the technology’s capabilities. The event promises to deliver valuable insights into how the system can potentially revolutionize treatment protocols for VT.
Commitment to Innovation and Patient Outcomes
Field Medical's participation in Heart Rhythm 2025 highlights its unwavering commitment to advancing cardiac health technologies. The company embraces a mission focused on improving patient outcomes through innovative solutions that respond to the ever-evolving needs of the electrophysiology community. By participating in numerous sessions, including panel discussions and presentations, Field Medical aims to drive conversations that could reshape the future of cardiac ablation.
About Field Medical Inc.
Founded in 2022, Field Medical is committed to developing next-generation pulsed field ablation technologies, designed to meet the complex demands of modern cardiac procedure. Led by Dr. Steven Mickelsen, a forerunner in pulsed electric field technology, the firm is at the cusp of advancing innovative solutions that enhance procedural outcomes in the field of electrophysiology. In addition to its pioneering research, the FDA's recognition of its technology with Breakthrough Device Designation emphasizes its significance in transforming cardiac treatment methodologies.
Frequently Asked Questions
What is the FieldForce Ablation System?
The FieldForce Ablation System is a high-voltage, focal pulsed field ablation catheter designed to create targeted lesions for effectively treating scar-related ventricular tachycardia.
When will the results of the VCAS trial be shared?
The trial results will be unveiled at the Heart Rhythm Society meeting on April 27, showcasing the outcomes from the first-in-human evaluation of focal PFA for VT.
How many presentations will Field Medical have at Heart Rhythm Society 2025?
Field Medical will feature eight presentations, including live case demonstrations, poster sessions, and a flagship symposium during the conference.
Who is presenting the live case demonstrations?
The live case demonstrations will be led by renowned electrophysiologists, including Dr. Vivek Reddy and Dr. Petr Neužil, showcasing innovative procedures using the FieldForce technology.
What is the significance of the Breakthrough Device Designation?
The Breakthrough Device Designation by the FDA recognizes the innovation and potential of Field Medical's technology, facilitating faster access to market and potentially advancing patient treatment options.
